These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19473124)
21. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Mihailovic-Stanojevic N; Jovovic D; Miloradovic Z; Grujic-Milanovic J; Jerkic M; Markovic-Lipkovski J Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260 [TBL] [Abstract][Full Text] [Related]
22. Vascular effects of a tripeptide fragment of novokinine in hypertensive rats: Mechanism of the hypotensive action. Bądzyńska B; Lipkowski AW; Sadowski J; Kompanowska-Jezierska E Pharmacol Rep; 2014 Oct; 66(5):856-61. PubMed ID: 25149991 [TBL] [Abstract][Full Text] [Related]
23. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats. Klinger F; Grimm R; Steinbach A; Tanneberger M; Kunert-Keil C; Rettig R; Grisk O Acta Physiol (Oxf); 2008 Mar; 192(3):429-42. PubMed ID: 17892519 [TBL] [Abstract][Full Text] [Related]
24. Effects of angiotensin II type-1 receptor blocker losartan on age-related cardiovascular risk in spontaneously hypertensive rats. Mihailović-Stanojević N; Miloradović Z; Grujić-Milanović J; Ivanov M; Jovović D Gen Physiol Biophys; 2009; 28 Spec No():112-8. PubMed ID: 19893088 [TBL] [Abstract][Full Text] [Related]
25. Differential effect of losartan in female and male spontaneously hypertensive rats. de P Rodrigues SF; dos Santos RA; Silva-Antonialli MM; Scavone C; Nigro D; Carvalho MH; de Cássia Tostes R; Fortes ZB Life Sci; 2006 Apr; 78(19):2280-5. PubMed ID: 16337658 [TBL] [Abstract][Full Text] [Related]
26. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition. Guidi E; Hollenberg NK J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668 [TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. Mori T; Cowley AW; Ito S J Pharmacol Sci; 2006 Jan; 100(1):2-8. PubMed ID: 16404134 [TBL] [Abstract][Full Text] [Related]
28. Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats. Marchand EL; Der Sarkissian S; Hamet P; deBlois D Circ Res; 2003 Apr; 92(7):777-84. PubMed ID: 12623880 [TBL] [Abstract][Full Text] [Related]
29. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone. Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944 [TBL] [Abstract][Full Text] [Related]
31. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats. Liu KL Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):455-61. PubMed ID: 19215237 [TBL] [Abstract][Full Text] [Related]
32. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension. Díez J Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167 [TBL] [Abstract][Full Text] [Related]
34. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats. Xie QY; Sun M; Yang TL; Sun ZL Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797 [TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney. Esteban V; Gallego-Delgado J; Lazaro A; Osende J; Mezzano S; Egido J; Ruiz-Ortega M J Nephrol; 2006; 19(6):725-31. PubMed ID: 17173244 [TBL] [Abstract][Full Text] [Related]
36. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats]. Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840 [TBL] [Abstract][Full Text] [Related]
37. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Mercier N; Labat C; Louis H; Cattan V; Benetos A; Safar ME; Lacolley P Am J Hypertens; 2007 Mar; 20(3):319-25. PubMed ID: 17324746 [TBL] [Abstract][Full Text] [Related]
38. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging? Baumann M; Bartholome R; Peutz-Kootstra CJ; Smits JF; Struijker-Boudier HA Am J Hypertens; 2008 Feb; 21(2):177-82. PubMed ID: 18188163 [TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats. Heeba GH Pharmacology; 2011; 87(3-4):232-40. PubMed ID: 21474976 [TBL] [Abstract][Full Text] [Related]
40. Blockade of angiotensin II and aging: is the spontaneously hypertensive rat a suitable model? Tuttle JB J Hypertens; 2006 Jan; 24(1):27. PubMed ID: 16331094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]